SCHEMBL3523274

SCHEMBL3523274

NS(=O)(=O)c1cccc(Nc2nccc(-c3ccc(NC(=O)c4cccs4)cc3)n2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.65
PDGFRB P09619 1/20 0.65
SRC P12931 1/20 0.65
PDGFRA P16234 1/20 0.65
CDK1 P06493 6/20 0.64
MTOR P42345 6/20 0.64
CDK2 P24941 5/20 0.64
PIK3CA P42336 2/20 0.64
PIK3CG P48736 2/20 0.64
IKBKB O14920 5/20 0.63
TTK P33981 2/20 0.53
CCNT1 O60563 1/20 0.53
CCNB1 P14635 1/20 0.53
CCNA2 P20248 1/20 0.53
CDK7 P50613 1/20 0.53
CDK9 P50750 1/20 0.53
CCNH P51946 1/20 0.53
CCNA1 P78396 1/20 0.53
SMG1 Q96Q15 5/20 0.53
JAK2 O60674 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4000628 0.87 ABL1 (0.69) ABL1PDGFRBSRCPDGFRAIKBKB
SCHEMBL4002108 0.86 ABL1 (0.71) ABL1PDGFRBSRCPDGFRACDK2
SCHEMBL3518244 0.86 IKBKB (0.85) CDK1MTORCDK2PIK3CAPIK3CG
SCHEMBL7524252 0.80 CDK1 (0.69) ABL1SRCCDK1MTORCDK2
SCHEMBL2941787 0.79 ABL1 (0.75) ABL1PDGFRBSRCPDGFRANPC1
SCHEMBL3516842 0.79 IKBKB (0.65) CDK1MTORCDK2PIK3CAPIK3CG
SCHEMBL1762 0.79 ABL1 (1.00) ABL1PDGFRBSRCPDGFRASMN1; SMN2
SCHEMBL3518288 0.79 IKBKB (0.82) CDK1MTORCDK2PIK3CAPIK3CG
SCHEMBL3521443 0.79 IKBKB (0.81) CDK1MTORCDK2PIK3CAPIK3CG
SCHEMBL2946111 0.78 CDK1 (0.63) ABL1SRCCDK1MTORCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799915-B2 Anilino-pyrimidine analogs WYETH LLC (US) 2010-09-21 US claimed
CN-101039919-A N-benzenesulfonyl substituted anilino-pyrimidine analogs WYETH CORP (US) 2007-09-19 CN claimed
US-20060079543-A1 Anilino-pyrimidine analogs WYETH (US) 2006-04-13 US claimed
CN-101039919-A N-benzenesulfonyl substituted anilino-pyrimidine analogs WYETH CORP (US) 2007-09-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079543-A1 Anilino-pyrimidine analogs DPYD, TYMP, ADORA3 ABL1 206/4885PDGFRB 194/4885SRC 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.